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Introduction: Increased carotid intima-
media thickness (IMT) is considered a 
marker of early-onset atherosclerosis and 
it seems to predict cardiovascular events 
in general population. The prognostic 
value of IMT in patients with early-stage 
chronic kidney disease (CKD) has not 
been clearly established. Objective: We 
aimed to evaluate the association between 
IMT and cardiovascular (CV) events and 
mortality in CKD patients. Methods: A 
cohort of CKD patients in stage 2-4 was 
evaluated the occurrence of CV events 
and death in a 24 months follow-up. Lab-
oratory data, carotid ultrasound and cor-
onary computed tomography were per-
formed at baseline. Results: A total of 117 
patients (57 ± 11 years-old, 61% male) 
were evaluated. Mean glomerular filtra-
tion rate (eGFR) was 36 ± 17 mL/min, 
96% of patients had hypertension, 23% 
diabetes and 27% were obese. Coronary 
calcification was found in 48% of the 
patients, with higher prevalence among 
CKD stage 4 (p = 0.02). The median value 
of IMT was 0.6 mm (0.4-0.7 mm). When 
compared to patients with IMT ≤ 0.6 mm, 
those with IMT > 0.6 mm were older (p = 
0.001), had higher prevalence of male (p = 
0.001) and had lower eGFR (p = 0.01). 
These patients also had higher prevalence 
of coronary calcification (p = 0.001). 
During the follow-up, there were no dif-
ferences in the occurrence of cardiovas-
cular events and deaths between the two 
groups. Conclusion: IMT in early-stage 
CKD patients was related to coronary cal-
cification, but not with the occurrence of 
cardiovascular events or death.
abstRact
Keywords: cardiovascular diseases, carotid 
intima-media thickness, mortality, renal 
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intRoduction
The pathophysiological mechanisms 
of atherosclerosis in chronic kidney 
disease (CKD) patients are not yet fully 
established. However, it is known that 
in addition to the traditional risk factors 
described in the Framingham Heart study, 
other factors related to uremia such as 
hyperphosphatemia, hyperparathyroidism 
and increased proinflammatory cytokine 
play a role in the development of the 
disease in this population.1,2
The measurement of the intima-media 
thickness (IMT) by ultrasonography 
(USG) of the carotid artery has been used 
to identify and monitor preclinical chan-
ges caused by atherosclerosis and it is cur-
rently recommended for cardiovascular 
risk assessment.3,4 In fact, in the general 
population, the carotid artery IMT is an 
independent predictor of coronary heart 
disease after adjustment for the risk of 
cardiovascular disease factors.5,6 Some 
studies have indicated IMT as a predictor 
of cardiovascular events in patients un-
dergoing hemodialysis.7-10 However, there 
are only few studies evaluating the IMT 
in the early stages of CKD, with incon-
sistent data.11-13 This study aimed at eva-
luating the association between IMT and 
the occurrence of cardiovascular events 
and mortality in patients with CKD in the 
non-dialysis stage.
mEthods
This is a post hoc analysis of a prospective 
study in which 117 patients were followed 
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up for a period of 24 months.2,14 All the patients were 
over 18 years of age and had been followed up by 
a nephrologist for at least three months. Exclusion 
criteria were: chronic inflammatory disease, 
confirmed neoplasia, HIV, viral hepatitis and chronic 
use of corticosteroids. Among these patients, 82% 
were taking angiotensin-converting enzyme (ACE) 
inhibitors; 77% were on diuretics; 42% were on 
beta blockers and 42% were taking calcium channel 
blockers. The use of statins was observed in 34% of 
the patients; 32% were taking Sevelamer; 5% were 
on Calcitriol and 5% were taking calcium carbonate. 
The aforementioned drugs were maintained during 
the follow-up period.
All the patients signed the informed consent form, 
and the study was approved by the Ethics Committee 
of the Federal University of São Paulo.
study protocol
At baseline, all the patients were submitted to 
laboratory tests, measurement of calcium score using 
coronary CT and carotid thickness measurement 
by USG. Cardiovascular events (angina, myocardial 
infarction, and stroke) or death were recorded for 24 
months.
laboratory aNalysis
Blood samples were taken after 12 hours 
of fasting, and included serum creatinine, 
hemoglobin, phosphorus, ionized calcium, alkaline 
phosphatase, intact parathyroid hormone [(iPTH), 
chemiluminescence immunoassay (Immulite, DPC-
Biermann, Bad Nauheim, Germany)], cholesterol and 
triglycerides. The glomerular filtration rate (eGFR) 
was estimated using the CKD-EPI (Chronic Kidney 
Disease Epidemiology Collaboration) equation.15 
Urinary protein was measured after a 24-hour 
collection, diagnosing proteinuria when the protein 
concentration exceeded 150 mg/24h.
Hyperphosphatemia, hyperparathyroidism and 
hypercalcemia were considered when serum levels 
of calcium, phosphorus and PTH were above the 
normal range (> 4.6 mg/dL, > 1.40 mmol/L and > 
65 pg/mL, respectively) according to the guidelines 
from the Kidney Disease Improving Global Outcomes 
(KDIGO) [Guideline on Mineral and Bone Disorder 
of Chronic Kidney Disease]16
coroNary artEry calcificatioN
Coronary calcification was determined using a 
16-channel multislice CT scanner (LightSpeed Pro 
16 - GE Healthcare, Milwaukee, USA), 0.4 s gantry 
rotation, 2.5 mm collimation, six takes per second 
of reconstruction time. A cutoff point equal to or 
higher than 130 Hounsfield units (HU) was used to 
determine the presence of calcium. Image acquisition 
time was synchronized with the cardiac cycle diastole 
by electrocardiographic monitoring.
The images were analyzed by a radiologist 
without access to patient clinical or biochemical 
information. As per described by Agatston, the 
calcium score was determined by multiplying the 
area of each calcified lesion by a numerical factor 
corresponding to the peak intensity of the pixels 
for each lesion. For analysis purposes, we used 
the sum of the lesions of all coronary arteries, 
represented by its numerical value in Agatston 
units (AU) [Agatston et al., 1990]. Coronary 
calcification was defined by having a calcium 
score above 10 AU.
ultrasoNography
The carotid artery IMT measurement was carried out 
in all patients by high resolution ultrasonography 
(Ultramark HDI 3000, ATL Ultrasound 
Incorporation, Bothell, USA) using a linear probe 
and a 7.0 MHz variable focus digital transducer, as 
described previously [Pignoli et al., 1986; Gariepy 
et al., 1993]. The examinations were performed in 
the morning by an examiner without access to the 
patients’ clinical or biochemical information. IMT 
was obtained by measuring the distance between two 
echogenic lines represented by the artery wall lumen-
intima and media-adventitia interfaces. Since the 
USG is unable to differentiate the intima layer from 
the media, the measure represents the value of the 
intima-media complex. According to the VI Brazilian 
Hypertension Guidelines, an IMT value greater than 
0.9 mm was considered abnormal.17
statistical aNalysis
The variables’ values were described as mean ± 
standard deviation (SD), median and interquartile 
range or frequency. Due to the small number of 
patients in stage 5 (n = 5), they were grouped 
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with those in stage 4. To compare the groups 
we used the unpaired t-test, Mann-Whitney and 
ANOVA, when appropriate. The Bonferroni 
test was used as an ANOVA complement when 
there were differences between the groups. For 
categorical variables we used the chi-square. The 
correlation between the IMT and other variables 
was assessed using the Spearman correlation. The 
cardiovascular event-free time and survival were 
assessed by Kaplan-Meier curves. The comparison 
between the curves was performed using the 
log-rank test, considering a significance level of 
5%. A p value of less than 0.05 was considered 
significant. The calculations were performed using 
the SPSS 18.0 for Windows® (SPSS Inc., Chicago, 
USA).
REsults
Table 1 depicts the characteristics of the 117 
patients enrolled in the study. The patients were 
predominantly male; 23% were diabetic and 27% 
were obese (body mass index greater than 30 kg/m2). 
Proteinuria was found in 58% of the subjects. Values 
above 200 mg/dL of total cholesterol were found 
in 32% of the individuals. Fifty-six patients (48%) 
had LDL cholesterol levels above 100 mg/dL, 22% 
had HDL cholesterol below 40 mg/dL and 43% had 
triglyceride levels greater than 150 mg/dL. In relation 
to changes in bone and mineral metabolism, 36% of 
patients had high concentrations of iPTH, 13% had 
hyperphosphatemia and 2.5% hypercalcemia.
Seventeen patients (14%) were in stage 2; 46 
(39%) in stage 3 and 54 (47%) were in stage 4/5. 
There were more men in stage 4/5, with higher 
phosphorus, alkaline phosphatase and PTH; and 
lower hemoglobin concentrations. There was a lower 
prevalence of hypertension in stage 3. There were no 
differences in the other variables.
Fifty-six patients (48%) had coronary artery 
calcification (CAC), and the calcium score of these 
patients was 334 AU (108-856 AU). There were no 
significant differences in the calcium score between 
different CKD stages; however, the prevalence of 
patients with calcification was significantly higher in 
more advanced stages (11 versus 21 versus 42%; p = 
0.02; stages 2, 3 and 4/5, respectively).
The median IMT was 0.60 mm (0.47 to 0.72 
mm). Only eight patients had values greater than 0.90 
mm, two on stage 3 and 6 in stages 4/5. There was a 
tendency to higher IMT values in CKD stages 4/5 (p = 
0.09, Figure 1A). There was a higher ratio of patients 
with values above the median for IMT in the more 
advanced stages of CKD (p = 0.03, Figure 1B). There 
was a correlation between IMT and the calcium score, 
as shown in Figure 2.
During the study, 20 patients started dialysis, we 
lost the follow up of nine patients and one patient 
underwent renal transplantation. There were 15 
cardiovascular events and four deaths in this period. 
The cardiovascular events were angina (n = 4); 
stroke (n = 3); acute myocardial infarction (n = 3); 
hypertensive emergency (n = 2); arrhythmia (n = 1); 
transient ischemic attack (n = 1) and heart failure 
(n = 1). One patient in stage 2 and three in stages 4/5 
died. The deaths were attributed to acute myocardial 
infarction, pancreatitis, accident and unknown cause. 
The IMT value did not differ among the patients who 
had cardiovascular events [0.60 mm (0.46 to 0.72 
mm) vs. 0.70 mm (0.50 to 0.82 mm), p = 0.75], or 
who died [0.60 mm (0.53 to 0.70 mm) vs. 0.66 mm 
(0.47 to 0.72 mm), p = 0.60].
Table 2 shows that patients with IMT above the 
median (≥ 0.60 mm) were older, predominantly males, 
and had lower glomerular filtration rates, also with a 
higher ratio of patients with coronary calcification. 
Cardiovascular events (9% vs. 16%, p = 0.26) and 
death (1.8 % vs. 4.8%, p = 0.37) were similar in both 
groups. As we can see in Figures 3A and 3B, the times 
free from cardiovascular events and death did not 
differ between the two groups.
discussion
In this study, over 90% of patients with CKD in the 
pre-dialysis stage had carotid IMT values within 
the normal limits set by the VI Brazilian Guidelines 
on Hypertension. However, a relationship was 
found between IMT and the presence of coronary 
calcification at baseline. Within the 24-month follow 
up, the IMT was not associated with cardiovascular 
events or death.
The mean IMT values described in cohorts of 
patients with CKD are quite large and vary between 
0.50 to 1.03 mm.13,18 This variation can be partly 
explained by the heterogeneity of the populations 
studied, with the inclusion of patients on dialysis, 
higher or lesser ratios of patients with diabetes; and 
the use of different techniques to measure IMT.4 
The low IMT value found in this population could 
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tablE 1 populatioN charactEristics at thE basEliNE
Characteristic All Stage 2 Stage 3 Stages 4-5 p value
Number (%) 117 17 (15) 46 (39) 54 (46)
Age (years) 57 ± 11 56 ± 9 55 ± 12 58 ± 11 0.44
Men (%) 46 (39) 6 (35) 13 (28) 27 (50) 0.11
Hypertension (%) 113 (96) 17 (100) 42 (91) 54 (100) 0.02
Diabetes (%) 27 (23) 4 (23) 10 (22) 13 (24) 0.96
BMI (kg/m2) 27 ± 5 30 ± 6 26 ± 5 26 ± 5 0.06
Creatinine (mg/dL) 1.8 ± 0.9 0.94 ± 0.24 1.4 ± 0.7 2.3 ± 0.8 0.001a
eGFR (mL/min/1,73m2) 36 ± 17 69 ± 7 42 ± 9 21 ± 5 0.001a
Proteinuria (mg/24h) 205 (0-650) 0 (0-287) 165 (0-562) 255 (0-822) 0.56
Hemoglobin (g/dL) 12.8 ± 1.8 13.3 ± 1.2 12.9 ± 1.6 11.6 ± 1.7 0.001a
Phosphorus (mg/dL) 3.8 ± 0.7 3.3 ± 0.6 3.6 ± 0.6 4.0 ± 0.8 0.001b
Ion Calcium (mmol/L) 1.3 ± 0.6 1.3 ± 0.5 1.3 ± 0.7 1.3 ± 0.5 0.57
Alkaline Phosphatase (U/L) 81 (66-103) 72 (60-87) 80 (80-103) 83 (68-111) 0.11
Parathormone (pg/mL) 103 (62-192) 56 (39-100) 80 (47-141) 158 (92-257) 0.001b
LDL Cholesterol (mg/dL) 101 ± 28 98 ± 18 105 ± 34 99 ± 24 0.48
HDL Cholesterol (mg/dL) 50 ± 14 51 ± 18 49 ± 12 52 ± 14 0.44
Triglycerides (mg/dL) 127 (98-192) 147 (74-248) 122 (98-203) 127 (102-173) 0.35
Calcium Score (UA) 9 (0-325) 42 (0-223) 0 (0-144) 24 (0-459) 0.26
Intima-media thickness (mm) 0.6 (0.4-0.7) 0.5 (0.4-0.6) 0.6 (0.4-0.7) 0.6 (0.4-0.8) 0.09
Values in mean ± DP, median (interquartile interval) or numbers (percentage). a All the stages are different; b Only stage 4 is different; BMI: Body 
Mass Index; GFR: Glomerular Filtration Rate.
Figure 1. Intima-media thickness at the different CKD stages (A) 
percentage of patients with IMT ≥ 0,6 mm (B).
Figure 2. Correlation between intima-media thickness (IMT) and 
calcium score.
suggest that selected patients in this study had a low 
cardiovascular risk; however, the measured values are 
equivalent to those reported by other authors who 
evaluated patients with similar characteristics.12,18
Several factors have been implicated in the genesis 
of atherosclerosis.1,3 Men have a higher prevalence 
of atherosclerosis, and the cause of this increased 
vulnerability has not yet been fully elucidated. It 
is suggested that the lower amount of circulating 
estrogen, to which vasodilation properties are assigned, 
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tablE 2 populatioN charactEristics aNd aNalysis of thE populatioN brokEN dowN accordiNg to imt mEdiaN valuE
Characteristic IMT < 0.6 IMT ≥ 0.6 p value
Number (%) 55 (47) 62 (53)
Age (years) 51 ± 11 62 ± 8 0.001
Men (%) 25 (25) 47 (75) 0.001
Hypertension (%) 52 (94) 61 (98) 0.25
Diabetes (%) 12 (21) 15 (24) 0.76
BMI (Kg/m2) 27 ± 6 26 ± 5 0.61
Creatinine (mg/dL) 1.6 ± 5.2 1.9 ± 0.2 0.07
eGFR (mL/min/1,73m2) 41 ± 19 33 ± 16 0.01
Proteinuria (mg/24h) 340 (0-600) 500 (0-500) 0.46
Hemoglobin (g/dL) 12.3 ± 1.8 12.5 ± 1.7 0.67
Phosphorus (mg/dL) 3.2 ± 0.9 3.3 ± 0.7 0.91
Ion Calcium (mmol/L) 1.28 ± 0.06 1.3 ± 0.6 0.58
Alkaline phosphatase (U/L) 77 (36-263) 84.5 (48-260) 0.11
Parathormone (pg/mL) 110 (18-502) 97 (20-1100) 0.65
LDL cholesterol (mg/dL) 100 ± 30 102 ± 26 0.92
HDL cholesterol (mg/dL) 51 ± 13 51 ± 15 0.93
Triglycerides (mg/dL) 159 (48-680) 156 (41-467) 0.83
Calcium score (UA) 0 (0-18) 138 (1-639) 0.22
Calcified patients (%) 16 (29) 42 (67) 0.001
Figure 3. Time free from cardiovascular events and patient survival, 
according to the intima-media thickness value.
can be an explanation.19,20 The association between 
age and atherosclerosis reflects the degeneration the 
endothelium undergoes over the years - probably a 
consequence of the exposure to risk factors such as 
hypertension, oxidative stress, and hyperglycemia 
among others.2 In the present study, the IMT was 
associated to both age and male gender.
An association between loss of renal function and 
increased IMT has been described;18,21-23 however, we 
have a study that does not report such association.12 
In our study, we found more patients with IMT 
above the median value in the later stages of CKD 
- suggesting that uremia, and related factors, such 
as hypertension, diabetes, dyslipidemia, disorders 
of bone and mineral metabolism, inflammation and 
increased oxidative stress may induce or aggravate 
the atherosclerotic process in this population.24-27
Studies on the relationship between IMT and 
vascular calcification in CKD are scarce. Kurnatowska 
et al.,28 upon assessing dialysis patients, found a direct 
correlation between the IMT and the calcium score. 
This data is similar to what we found in our study 
that evaluated patients in the early stages of CKD. 
Vascular calcification is prevalent and early, being 
found in all stages of kidney disease.29,30 Coronary 
calcification is associated with a significant increased 
risk of cardiovascular events in this population.14,31
Different studies have investigated the relationship 
between IMT and cardiovascular events.1 In agreement 
with our study, Zoungas et al.13 found no association. 
However, Szeto et al.11 found that the IMT was a 
strong predictor of cardiovascular events in a cohort 
of patients with CKD stages 3 and 4. It is noteworthy 
in this study that the median IMT was 0.8 mm, 
indicating a population with more advanced lesions 
than those found in our population. In addition, a 
longer study time (48 months) allowed the occurrence 
of a greater number of cardiovascular events. It is 
noteworthy that, like our study, Szeto et al.11 found 
no association between IMT and mortality. However, 
the association between IMT and mortality has been 
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described in patients undergoing dialysis.32 In this 
study, the authors report the occurrence of death in 
30% of patients at 2 years follow-up. In our study, 
with the same follow-up period, we had only 3% of 
death, suggesting a greater severity of cardiovascular 
lesions in patients undergoing dialysis.
Despite the relatively small sample and reduced 
occurrence of cardiovascular events and deaths 
during follow-up, our study confirms that the IMT 
is a marker of cardiovascular disease - having seen 
its relationship with the calcification score. Further 
studies are needed to evaluate the IMT in patients 
with CKD.
conclusion
The intima-media thickness in patients with 
CKD not requiring dialysis is associated with 
coronary calcification, but not to the occurrence 
of cardiovascular events and death in a 24-month 
follow-up.
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